Crea il mio profilo
Accesso pubblico
Visualizza tutto6 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Jean-Luc BredasThe University of ArizonaEmail verificata su email.arizona.edu
- Seth MarderUniversity of Colorado-Boulder and National Renewable Energy LaboratoryEmail verificata su colorado.edu
- Joseph W. PerryProfessor of Chemistry and BiochemistryEmail verificata su gatech.edu
- Ola EngkvistAstraZeneca R&D Gothenburg Orcid:0000-0003-4970-6461Email verificata su astrazeneca.com
- Chris XuIBM Chair Professor of Applied and Engineering Physics, Cornell UniversityEmail verificata su cornell.edu
- Sam HessProfessor of Physics, University of MaineEmail verificata su maine.edu
- Sorel MuresanR&D Manager HPC EMEA, Nouryon, Stenungsund SwedenEmail verificata su nouryon.com
- Hongming ChenBioland LaboratoryEmail verificata su grmh-gdl.cn
- Niklas BlombergDirector, ELIXIREmail verificata su ebi.ac.uk
- Mark P WallerPending.AIEmail verificata su pending.ai
- Mikko J. VainioAstraZeneca AB, Mölndal, SwedenEmail verificata su abo.fi
- Christopher SouthanInformatics, Medicines Discovery CatapultEmail verificata su md.catapult.org.uk
- Lars CarlssonRTHS and CRML, University of LondonEmail verificata su rhul.ac.uk
- Elin Soffia OlafsdottirProfessor in Natural Product ChemistryEmail verificata su hi.is
- Sesselja OmarsdottirAssociate Professor of Pharmaceutical Natural Product Chemistry, University of IcelandEmail verificata su hi.is
- Jason Grant KettlePrincipal Scientist, Medicinal Chemistry, Oncology iMED, AstraZenecaEmail verificata su astrazeneca.com
- Matthew W D PerryMedicinal Chemistry, RIA iMed, AstraZenecaEmail verificata su astrazeneca.com
- Frederick W GoldbergGlobal Project Leader (Senior Director), Oncology R&D, AstraZenecaEmail verificata su astrazeneca.com
- Egbert ZojerGraz University of TechnologyEmail verificata su tugraz.at
- Philippe DuboisUniversity of Mons - UMONS & MATERIA NOVA sableEmail verificata su umons.ac.be